Stay updated on INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.

Latest updates to the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange Detected- Added a government funding and operating-status notice and updated the version to v3.2.0. - Removed the specific resource topic “Genetic and Rare Diseases Information Center resources: Carcinoma of esophagus” and downgraded the revision from v3.1.0 to v3.2.0.SummaryDifference3%
- Check18 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated to include new drug information for Nivolumab and Ipilimumab, as well as resources related to esophageal carcinoma, while removing previous references to Trastuzumab and other related topics.SummaryDifference4%
- Check53 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.1%
Stay in the know with updates to INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.